rs372580668

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_001036.6(RYR3):​c.12778A>G​(p.Ile4260Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,613,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00017 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000027 ( 0 hom. )

Consequence

RYR3
NM_001036.6 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.843

Publications

0 publications found
Variant links:
Genes affected
RYR3 (HGNC:10485): (ryanodine receptor 3) The protein encoded by this gene is a ryanodine receptor, which functions to release calcium from intracellular storage for use in many cellular processes. For example, the encoded protein is involved in skeletal muscle contraction by releasing calcium from the sarcoplasmic reticulum followed by depolarization of T-tubules. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
RYR3 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen, G2P
  • congenital myopathy
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.020034611).
BP6
Variant 15-33838758-A-G is Benign according to our data. Variant chr15-33838758-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 461854. Variant chr15-33838758-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 461854. Variant chr15-33838758-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 461854. Variant chr15-33838758-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 461854. Variant chr15-33838758-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 461854. Variant chr15-33838758-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 461854. Variant chr15-33838758-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 461854. Variant chr15-33838758-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 461854.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RYR3NM_001036.6 linkc.12778A>G p.Ile4260Val missense_variant Exon 89 of 104 ENST00000634891.2 NP_001027.3 Q15413-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RYR3ENST00000634891.2 linkc.12778A>G p.Ile4260Val missense_variant Exon 89 of 104 1 NM_001036.6 ENSP00000489262.1 Q15413-1

Frequencies

GnomAD3 genomes
AF:
0.000171
AC:
26
AN:
152166
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000603
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000723
AC:
18
AN:
249030
AF XY:
0.0000518
show subpopulations
Gnomad AFR exome
AF:
0.000775
Gnomad AMR exome
AF:
0.000174
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000267
AC:
39
AN:
1461680
Hom.:
0
Cov.:
32
AF XY:
0.0000248
AC XY:
18
AN XY:
727116
show subpopulations
African (AFR)
AF:
0.000747
AC:
25
AN:
33480
American (AMR)
AF:
0.000201
AC:
9
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53402
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1111848
Other (OTH)
AF:
0.0000497
AC:
3
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000171
AC:
26
AN:
152166
Hom.:
0
Cov.:
32
AF XY:
0.000108
AC XY:
8
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.000603
AC:
25
AN:
41438
American (AMR)
AF:
0.0000654
AC:
1
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68018
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000259
Hom.:
0
Bravo
AF:
0.000181
ESP6500AA
AF:
0.000504
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000662
AC:
8

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 04, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.12778A>G (p.I4260V) alteration is located in exon 89 (coding exon 89) of the RYR3 gene. This alteration results from a A to G substitution at nucleotide position 12778, causing the isoleucine (I) at amino acid position 4260 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Epileptic encephalopathy Benign:1
Aug 17, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
0.28
DANN
Benign
0.28
DEOGEN2
Uncertain
0.45
T;.;.;.;.;.
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.030
N
LIST_S2
Benign
0.72
T;T;T;T;T;T
M_CAP
Benign
0.041
D
MetaRNN
Benign
0.020
T;T;T;T;T;T
MetaSVM
Benign
-0.49
T
MutationAssessor
Benign
-0.20
N;.;.;.;.;.
PhyloP100
0.84
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.23
.;N;.;.;.;.
REVEL
Benign
0.15
Sift
Benign
0.57
.;T;.;.;.;.
Sift4G
Benign
0.30
.;.;.;.;.;T
Polyphen
0.0040
B;B;.;.;.;.
Vest4
0.091
MVP
0.093
MPC
0.15
ClinPred
0.0044
T
GERP RS
-3.7
PromoterAI
0.0073
Neutral
Varity_R
0.022
gMVP
0.16
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs372580668; hg19: chr15-34130959; API